MoneyWorks4Me

Natco Pharma informs about disclosure

20 Aug 2021 Evaluate

Natco Pharma has informed that it enclosed the disclosure titled ‘Legal update on Ibrutinib’ under Regulation 30 of SEBI (LODR) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..